Trial Profile
Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Jun 2023
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Cocaine-related disorders
- Focus Therapeutic Use
- 23 May 2018 Status changed from active, no longer recruiting to completed.
- 11 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2016.
- 11 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2017.